Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Novavax (0A3S) Share Price & Analysis

16 Followers

0A3S Stock Chart & Stats

$9.19-$0.82(-8.19%)
At close: 4:30 PM GMT
$7.5$10$12.5Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$9.15 - $10.05
52-Week Range
$6.16 - $13.33
Previous Close
$10.01
Volume
N/A
Average Volume (3M)
118.49K
Market Cap
$1.65B
Enterprise Value
$1.46B
Total Cash (Recent Filing)
$622.36M
Total Debt (Recent Filing)
$295.26M
Price to Earnings (P/E)
―
Beta
0.94
Next Earnings
Mar 04, 2027 (Est.)
EPS Estimate
0.54
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Sanofi Partnership Monetization

The Sanofi alliance provides validated commercial and development leverage for Novavax’s vaccine technology. More than $1 billion in cumulative revenue, additional milestones, and potential royalties create a meaningful partner-backed revenue stream beyond standalone COVID product sales.

Matrix-M Platform Validation

Matrix-M has progressed beyond a purely experimental platform into use in two commercial vaccines, including malaria. That validation supports broader licensing, supply, and collaboration opportunities while increasing the platform’s strategic value across infectious-disease programs.

Structural Cost Reduction

Planned expense reductions of more than $200 million, alongside a substantially smaller workforce, could materially lower the break-even level. If executed without undermining priority programs, the leaner structure should improve operating leverage and extend financial endurance.

Bears Say

Negative Shareholders’ Equity

Persistently negative equity weakens the company’s financial flexibility and makes leverage measures less favorable. It can constrain funding choices, increase dependence on successful partnerships or financing, and leave less balance-sheet capacity to absorb operating setbacks.

Persistent Cash Burn

Ongoing negative operating and free cash flow indicates that the current business does not yet consistently fund itself. Continued cash outflows can consume liquidity over time and make the company more reliant on milestones, partner receipts, cost cuts, or other external funding sources.

Revenue Volatility And Concentration

Sharp revenue swings and the scheduled decline of reimbursement and amortization contributions reduce top-line visibility. The resulting dependence on COVID demand, product sales, milestones, and new programs makes recurring revenue and sustainable profitability harder to establish.

Novavax News

0A3S FAQ

What was Novavax’s price range in the past 12 months?
Novavax lowest share price was $6.16 and its highest was $13.33 in the past 12 months.
What is Novavax’s market cap?
Novavax’s market cap is $1.65B.
When is Novavax’s upcoming earnings report date?
Novavax’s next earnings report is estimated for Mar 04, 2027 (not yet confirmed), which is in 111 days.
How were Novavax’s earnings last quarter?
Novavax released its earnings results on Nov 05, 2026. The company reported -$0.19 earnings per share for the quarter, beating the consensus estimate of -$0.346 by $0.156.
Is Novavax overvalued?
According to Wall Street analysts Novavax’s price is currently Undervalued.
Does Novavax pay dividends?
Novavax does not currently pay dividends.
What is Novavax’s EPS estimate?
Novavax’s EPS estimate is 0.54.
How many shares outstanding does Novavax have?
Novavax has 165,009,000 shares outstanding.
What happened to Novavax’s price movement after its last earnings report?
Novavax reported an EPS of -$0.19 in its last earnings report, beating expectations of -$0.346. Following the earnings report the stock price went down -7.514%.
Which hedge fund is a major shareholder of Novavax?
Hedge funds hold Novavax shares: the largest hedge-fund position in Novavax is 579,858,392 shares, and hedge funds decreased their holdings by 74.1K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology